Lipid Disorders
News
Empagliflozin slows renal disease progression in type 2 diabetes
Key clinical point: Compared with placebo, empagliflozin was associated with better renal outcomes among patients with type 2 diabetes and high...
News
FDA strengthens kidney warnings on two diabetes drugs
Conference Coverage
Simplify cardiac risk assessment for rheumatologic conditions
News
Phentermine-topiramate shows best chance of weight loss at 1 year
Key clinical point: The combination weight-loss drug phentermine plus topiramate is associated with the highest odds of individuals being able to...
News
Long-acting opioids increase cardiovascular deaths in noncancer patients
News
Adolescent obesity rose slightly, again
Nearly one in five children and adolescents are obese, and rates of adolescent obesity have risen during every time period measured since 1994.
News
Obesity continues to trend up among women over the past decade
Obesity rates among women have continued to rise over the past decade, but have leveled off among men.
News
Obesity paradox extends to TAVR but not SAVR
PARIS – Thirty-day and 1-year mortality rates were lowest in the top BMI quartile of TAVR patients and highest in the bottom BMI quartile.
Conference Coverage
Statins, but not aspirin, linked to lower pancreatic cancer risk
Key clinical point: Statin use was linked to lower odds of pancreatic ductal adenocarcinoma, while aspirin use was not. Major finding: Statin use...
Conference Coverage
Gas-filled gastric balloons achieve weight loss
A system that utilizes gas-filled gastric balloons helped obese people lose almost twice as much weight, compared with lifestyle modifications.
Conference Coverage
Marijuana may lower death risk after acute MI
CHICAGO – Patients who used marijuana prior to their acute MI had better outcomes.